Skip to content
★ Sign in to follow
MC

Mark Christopher Murray

Directeur des Biomatériaux
Avantor, Inc.Celanese Corp
Insider activity · 24 months4 buys0 salesCumulative net flow
Total declarations
21
Companies
2
▲ Purchases (7 ops.)
€656k
▼ Sales (0 ops.)
—

Latest filing published 12 Aug 2026 for Celanese Corp, €85k.

Filing timeline

BuySale
Mark Christopher Murray

Insider track record

Disclosed buys
7
Disclosed sells
0
T+90 hit rate
20%
T+90 mean return
-9.9%

Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Mark Christopher Murray: trading record in brief

Mark Christopher Murray, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Celanese Corp and Avantor, Inc. Between 13 January 2020 and 11 August 2026, the trades on record add up to 21 filings.

The open-market record is one-sided, with 7 purchases worth €656k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 14 share grants. Since January 2026: 1 purchase and no sales on the market.

Half of the purchases are above €85k and half below. Clusters matter here: 2 out of 7 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 12 August 2026 with an open-market purchase (€85k) in Celanese Corp. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Mark Christopher Murray

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total

16 of 16 declarations